ProVerum Limited
ProVerum Limited is a medical technology company specializing in the development of the ProVee® System, a minimally invasive solution designed to treat benign prostatic hyperplasia (BPH). The company focuses on providing innovative healthcare solutions to improve the quality of life for patients with BPH, a common condition affecting the prostate gland in men.
Leadership & Board
- Current Number of Employees
- 61
- Current LinkedIn Followers
- 4,502
Latest Estimated Valuation
- Estimated Valuation
- ―
- Total Amount Raised
- $80M
- Total Funding Rounds
- 1
- Latest Funding Amount
- $80M
- Latest Funding Round
- Series B
- Post-Money Valuation
- ―
Company Momentum Positive
ProVerum Limited LinkedIn following is increasing, signaling rising market interest, while its workforce is growing, indicating business expansion.
Employee Trend
ProVerum Limited had 61 employees as of October 12, 2026. The number of employees increased by 2 (3.39%) week-over-week.
Social Trend
ProVerum Limited had 4,502 followers as of October 12, 2026. The number of followers increased by 117 (2.67%) week-over-week.
Funding Round
| Funding Date | Funding Round | Amount Raised | Post-Money Valuation |
|---|---|---|---|
| Aug 25, 2025 | Series B | $80.00M | ― |
Investors
| Investor Name | Funding Round |
|---|---|
| OrbiMed | Series B |
| MVM Partners | Series B |
| Gilde Healthcare Partners | Series B |
| Ireland Strategic Investment Fund | Series B |
| Lightstone Ventures | Series B |
| Atlantic Bridge | Series B |
| Enterprise Ireland | Series B |
Similar Companies
A snapshot of private companies similar to ProVerum Limited, helping you discover and navigate related company profiles.
Related News and Analysis
